Edition:
United States

Ascendis Pharma A/S (ASND.OQ)

ASND.OQ on NASDAQ Stock Exchange Global Select Market

36.94USD
1:31pm EST
Change (% chg)

$0.11 (+0.30%)
Prev Close
$36.83
Open
$36.72
Day's High
$37.10
Day's Low
$36.56
Volume
12,541
Avg. Vol
53,150
52-wk High
$42.00
52-wk Low
$19.34

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.79 December 18 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 2 2 2 2
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.67 1.67 1.67 1.67

Consensus Estimates Analysis

Sales and Profit Figures in Euro (EUR)
Earnings and Dividend Figures in Euro (EUR)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 6 0.33 0.51 0.00 0.57
Quarter Ending Mar-18 2 0.75 1.10 0.40 --
Year Ending Dec-17 6 1.73 2.00 1.50 2.23
Year Ending Dec-18 6 2.04 4.25 0.80 2.34
Earnings (per share)
Quarter Ending Dec-17 5 -0.79 -0.60 -0.94 -0.44
Quarter Ending Mar-18 3 -0.74 -0.62 -0.89 --
Year Ending Dec-17 6 -3.47 -2.87 -3.66 -1.98
Year Ending Dec-18 6 -3.12 -2.48 -3.53 -2.41

Historical Surprises

Sales and Profit Figures in Euro (EUR)
Earnings and Dividend Figures in Euro (EUR)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 0.62 0.43 0.18 29.48
Quarter Ending Jun-17 0.78 0.44 0.34 43.19
Quarter Ending Mar-17 0.82 0.35 0.46 56.67
Quarter Ending Dec-16 0.99 1.04 0.05 5.40
Quarter Ending Sep-16 0.66 1.23 0.57 86.80

Consensus Estimates Trend

Sales and Profit Figures in Euro (EUR)
Earnings and Dividend Figures in Euro (EUR)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 0.33 0.33 0.63 0.63 0.57
Quarter Ending Mar-18 0.75 0.75 0.75 0.75 --
Year Ending Dec-17 1.73 1.73 1.92 1.92 2.23
Year Ending Dec-18 2.04 2.04 2.57 2.57 2.34

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 0 5
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 0 0 2
Year Ending Dec-18 0 0 0 5
Earnings